Physician profile
Christopher Wasacz
NPI 1841604394
$2,728.53
in general payments reported to CMS, 2019-2025
9 companies · $913 in 2025
The $913 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $193 · 2022: $284 · 2023: $1,321 · 2024: $17.68 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,465 · Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,465.44 |
| Food and Beverage | $785.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,508.45 | 2023-2025 | |
| Arthrex, INC. | $495.90 | 2023-2025 | |
| Bioventus LLC | $221.11 | 2021-2023 | Durolane |
| Lima USA, INC. | $147.36 | 2023 | Smr Shoulder |
| Ferring Pharmaceuticals INC. | $135.91 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $100.32 | 2021-2022 | |
| Stryker Corporation | $65.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $36.27 | 2022 | |
| Convatec INC. | $17.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wasacz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.